Viewing Study NCT06471205


Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-04-06 @ 5:50 AM
Study NCT ID: NCT06471205
Status: RECRUITING
Last Update Posted: 2025-05-07
First Post: 2024-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module